Shandong Luoxin Pharmacy Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Luoxin Pharmacy Group Co Ltd with three other
companies in this sector in China:
Hubei Jumpcan Pharmaceutical Co Ltd
sales of 3.74 billion Chinese Renmimbi [US$551.74 million]
of which 96%
was Industrial Manufacturing),
Zhejiang Huahai Pharmaceutical
(3.50 billion Chinese Renmimbi [US$516.17 million]
of which 52%
was Raw material & Intermediate Sale), and
China Medical System Holdings Limited
(3.55 billion Chinese Renmimbi [US$524.02 million]
of which 100%
was Pharmaceutical Products).
During the year ended December of 2015, sales at
Shandong Luoxin Pharmacy Group Co Ltd were 3.61 billion Chinese Renmimbi (US$532.57 million).
increase of 30.5%
versus 2014, when the company's sales were 2.77 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shandong Luoxin Pharmacy Group Co Ltd
(and since 2010, sales have increased a total of 169%).